Abstract: Some disclosed examples involve writing a test pattern of bits to one or more fields of at least one test packet and injecting the at least one test packet into a packet processing system of a network device. Some disclosed examples involve causing the at least one test packet to loop multiple times through ingress and egress portions of the packet processing system, trapping the at least one test packet and determining whether the test pattern of the at least one test packet has been altered.

Abstract: Methods and systems for modifying network traffic data. The method of modifying network traffic data may include receiving a network traffic data unit by a switching engine; performing an analysis on the network traffic data unit to obtain network tunnel information; generating encryption information based on the network tunnel information; and securing the network traffic data unit, by an encryption engine, based on the encryption information.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: A fungal culture is provided that incorporates concentrations of Fenton reactants and white rot fungi biomass. These components synergize to degrade recalcitrant organic compounds such as lignins, perfluorochemicals including PFOA, plastics, and related compounds, particularly with 1.5 mM H2O2, 1 mM Fe2+, and Phanerochaete chrysosporium exhibiting lignin degrading capabilities comparable to cultures of Fenton-only reaction mediums with significantly higher concentrations of hydrogen peroxide. Both the fungi and the Fenton reactants work to degrade the organic compounds. Additionally, the Fenton reactants impose oxidative stress on fast-growing microbial competitors such as E. coli, selectively inhibiting the competing bacteria and their disadvantageous effects on white rot fungi activity. The white rot fungi recycle Fe(II) ions to reduce Fenton reactant input burden. An electro-Fenton reaction process can further reduce this burden by replenishing H2O2.

Abstract: A command line interface in a network device provides for specifying Virtual Local Area Network (VLAN) tag manipulations using range mappings to avoid error-prone repetitive configuration. A flexible VLAN tag range mapping is described, where the original and transformed ranges can be specified for both inner and outer positions, as long as the number of tags on either side of the transformation is the same.

Abstract: Provided herein are recombinant vesicular stomatitis virus (rVSV) or rVSV vector comprising nucleic acid encoding the spike glycoprotein S of SARS-COV-2, compositions comprising such vectors or viruses, as well as screening methods, diagnostic methods, prophylactic and therapeutic methods using such vectors or viruses.

Abstract: A command line interface in a network device provides for specifying Virtual Local Area Network (VLAN) tag manipulations using range mappings to avoid error-prone repetitive configuration. A flexible VLAN tag range mapping is described, where the original and transformed ranges can be specified for both inner and outer positions, as long as the number of tags on either side of the transformation is the same.

Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: Anti-CCHFV antibodies with neutralizing potency and protective efficacy against CCHFV are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.

Abstract: The present invention is related to the development of therapeutics and prophylactics for the treatment and/or prevention of filovirus infection in humans and other mammals. A new class of small molecules is disclosed that inhibits the interaction of naturally processed (i.e., proteolytically cleaved) filovirus glycoprotein (GPCL) with its host receptor Niemann-Pick C1 (NPC1) protein and thus block infection of host cells by filoviruses. Also disclosed are methods of using the small molecule inhibitors in the treatment/prevention of filovirus infection.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially, similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.

Abstract: Methods and systems for modifying network traffic data. The method of modifying network traffic may include receiving a network traffic data unit that includes an identifier, at a proxy port; based on the identifier, performing a proxy port action set to obtain a modified network traffic data unit; and transmitting the modified network traffic data unit towards an egress port.

Abstract: Each switch unit in a networking system shares its local state information among other switch units in the networking system, collectively referred to as the shared forwarding state. Each switch unit creates a respective set of output queues that correspond to ports on other switch unites based on the shared forwarding state. A received packet on an ingress switch unit operating in accordance with a first routing protocol instance can be enqueued on an output queue in the ingress switch; the packet is subsequently processed by the egress switch unit, operating in accordance with a second routing protocol instance that corresponds to the output queue.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially, similar to those described herein, as well as affinity matured variants thereof, alone or in combination, provide therapeutic efficacy in a patient against multiple species of ebolavirus.

Abstract: Anti-CCHFV antibodies with neutralizing potency and protective efficacy against CCHFV are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.